New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
05:55 EDTSPPI, SPPI, WAT, WAT, HSIC, HSIC, ISIS, ISIS, THOR, THOR, GWAY, GWAY, HRC, HRC, HWAY, HWAY, MYGN, MYGN, BMRN, BMRN, DRRX, DRRX, MCK, MCKCredit Suisse to host a conference
2012 Healthcare Conference is being held in Phoenix on November 14-15.
News For MCK;DRRX;BMRN;MYGN;HWAY;HRC;GWAY;THOR;ISIS;HSIC;WAT;SPPI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 16, 2014
08:04 EDTDRRXDURECT grants Santen worldwide rights to sustained release SABER
Subscribe for More Information
07:06 EDTISISIsis Pharmaceuticals initiates phase 1/2 study of ISIS-DMPK Rx
Subscribe for More Information
06:36 EDTDRRXDURECT initiated with a Hold at Cantor
Subscribe for More Information
December 15, 2014
11:42 EDTMCKMcKesson management to meet with FBR Capital
Field trip to company headquarters to be held in San Francisco on December 18 hosted by FBR Capital.
December 12, 2014
08:01 EDTBMRNPiper predicts two large-cap biotechs could be acquired in 2015
Subscribe for More Information
December 11, 2014
12:54 EDTMYGNMyriad Genetics management to meet with William Blair
Subscribe for More Information
10:21 EDTBMRNHigh option volume stocks
Subscribe for More Information
09:28 EDTISISIsis Pharmaceuticals up 3% after CEO appears on Mad Money
Subscribe for More Information
07:46 EDTBMRNBioMarin could be $150 in 'blue skies' scenario, says UBS
Subscribe for More Information
07:35 EDTBMRNBioMarin price target raised to $107 from $92 at Leerink
Subscribe for More Information
07:24 EDTBMRNBioMarin price target raised to $104 from $90 at William Blair
William Blair raised its price target for BioMarin shares to $104 following the company's R&D day and keeps an Outperform rating on the stock. The firm expects the Vimizim launch to remain strong and believes BioMarin holds one of the strongest pipelines in the sector.
07:19 EDTBMRNBioMarin price target raised to $118-$122 from $103-$107 at Wells Fargo
Subscribe for More Information
December 10, 2014
08:14 EDTBMRNBioMarin VIMIZIM approved in Brazil
Subscribe for More Information
08:13 EDTBMRNBioMarin NAGLU granted ODD by FDA
Subscribe for More Information
December 9, 2014
12:22 EDTBMRNPiper Jaffray biopharm analyst holds an analyst/industry conference call
Senior Research Analyst Schimmer, along with Biopharmaceuticals Analyst Breazzano, discuss gene therapy for hemophilia on an Analyst/Industry conference call to be held on December 11 at 10 am.
07:44 EDTBMRNAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
December 8, 2014
11:30 EDTMCKLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
10:41 EDTISISIsis Pharmaceuticals price target raised to $81 from $62 at Piper Jaffray
Subscribe for More Information
08:00 EDTISISIsis Pharmaceuticals price target raised to $66 from $55 at Stifel
Subscribe for More Information
05:30 EDTISISIsis Pharmaceuticals to host conference call
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use